We systematically reviewed the literature and relevant data repositories to characterise the prevalence and spectrum of germline variants in breast and ovarian cancer susceptibility genes in the Indian population, including putative BRCA1 and BRCA2 founder mutations. This evidence concerns the gene BRCA1 and ovarian cancer.